CoChat

Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas

Open access
Peyre, M., Cartalat-Carel, S., Meyronet, D., Ricard, D., Jouvet, A., Pallud, J., Mokhtari, K., Guyotat, J., Jouanneau, E., Sunyach, M.-P., Frappaz, D., Honnorat, J., Ducray, F. · 2010 · Neuro-Oncology
Cited by 95

The DOI matches its Crossref record.

Abstract

Previous studies with temozolomide suggest that a prolonged duration of chemotherapy is important for treating low-grade gliomas (LGGs). PCV (procarbazine, CCNU, vincristine) chemotherapy has demonstrated efficacy in treating LGGs, but this therapy cannot be used for a prolonged period because of the cumulative toxicity. The aim of the present study was to evaluate the impact of first-line PCV chemotherapy on LGGs growth kinetics. The mean tumor diameter (MTD) of 21 LGGs was measured on serial magnetic resonance images before (n=13), during, and after PCV onset (n=21). During PCV treatment, a decrease in the MTD was observed in all patients. After PCV discontinuation, an ongoing decrease in MTD was observed in 20 of the 21 patients. Median duration of the MTD decrease was 3.4 years (range, 0.8-7.7) after PCV onset and 2.7 years (range, 0-7) after the end of PCV treatment with 60% of LGGs, demonstrating an ongoing and prolonged (>2 years) response despite chemotherapy no longer being administered. According to McDonald's criteria, the rates of partial and minor responses were 5% and 38% at the end of PCV but 38% and 42% at the time of maximal MTD decrease, which occurred after a median period of 3.4 years after PCV onset. These results challenge the idea that a prolonged duration of chemotherapy is necessary for treating LGGs and raise the issue of understanding the mechanisms involved in the persistent tumor volume decrease once chemotherapy is terminated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/neuonc/noq055

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 95

Metadata

Authors
Peyre, M., Cartalat-Carel, S., Meyronet, D., Ricard, D., Jouvet, A., Pallud, J., Mokhtari, K., Guyotat, J., Jouanneau, E., Sunyach, M.-P., Frappaz, D., Honnorat, J., & Ducray, F.
Venue
Neuro-Oncology
Published
2010-05-20
Volume
12
Issue
10
Pages
1078-1082
ISSN
  • 1522-8517 (ISSN-L)
  • 1523-5866
OpenAlex
W2129849427
Cited by
95
References
0
FWCI
4.02
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas. https://app.cochat.ai/papers/10.1093/neuonc/noq055
The paper
Peyre, M., Cartalat-Carel, S., Meyronet, D., Ricard, D., Jouvet, A., Pallud, J., Mokhtari, K., Guyotat, J., Jouanneau, E., Sunyach, M.-P., Frappaz, D., Honnorat, J., & Ducray, F. (2010). Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas. Neuro-Oncology. https://doi.org/10.1093/neuonc/noq055

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.